RT Journal Article
SR Electronic
T1 GIS-based spatial modeling to identify factors affecting COVID-19 incidence rates in Bangladesh
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.16.20175976
DO 10.1101/2020.08.16.20175976
A1 Md. Hamidur Rahman
A1 Niaz Mahmud Zafri
A1 Fajle Rabbi Ashik
A1 Md Waliullah
YR 2020
UL http://medrxiv.org/content/early/2020/08/17/2020.08.16.20175976.abstract
AB The outbreak of the COVID-19 pandemic is an unprecedented shock throughout the world which leads to generate a massive social, human, and economic crisis. However, there is a lack of research on geographic modeling of COVID-19 as well as identification of contributory factors affecting the COVID-19 in the context of developing countries. To fulfill the gap, this study aimed to identify the potential factors affecting the COVID-19 incidence rates at the district-level in Bangladesh using spatial regression model (SRM). Therefore, data related to 32 demographic, economic, weather, built environment, health, and facilities related factors were collected and analyzed to explain the spatial variability of this disease incidence. Three global (Ordinary least squares (OLS), spatial lag model (SLM) and spatial error model (SEM)) and one local (geographically weighted regression (GWR)) SRMs were developed in this study. The results of the models showed that four factors significantly affected the COVID-19 incidence rates in Bangladesh. Those four factors are urban population percentage, monthly consumption, number of health workers, and distance from the capital. Among the four developed models, the GWR model performed the best in explaining the variation of COVID-19 incidence rates across Bangladesh with a R2 value of 78.6%. Findings from this research offer a better insight into the COVID-19 situation and would help to develop policies aimed to prevent the future epidemic crisis.Competing Interest StatementThe authors have declared no competing interest.Clinical Trialwas not registeredFunding Statementno external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No need to take IRB approvalAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be shared on request